Good news, migraine sufferers! Amgen just posted positive data for its drug | Traderszone

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 8 June, 2016 by The TZ Newswire Staff

Good news, migraine sufferers! Amgen just posted positive data for its drug

Amgen said Wednesday that it has seen positive results for the migraine prevention drug it has been developing with Novartis.

See also
- Next Article Dave & Buster’s edges higher after beating the Street
- Previous Article Elizabeth Warren to endorse Hillary Clinton imminently, won’t rule out VP run
Editorial Calender

June 2016

M T W T F S S

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28 29 30

« May Jul »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar